Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PDC Biotech GmbH

Latest From PDC Biotech GmbH

EdRIP raising €200M for new life sciences VC fund

Four years after closing the BioDiscovery 3 at €156 million, Edmond de Rothschild Investment Partners is now on the road raising a €200 million fourth fund to invest innovative European life sciences companies. The French venture capitalist started fundraising three weeks ago and is confident that it will be able to complete a first closing at more than €100 million by the end of April or early May.

Metabolic Disorders Gynecology & Urology

PDC Biotech plans trial of peptide to treat primary dysmenorrhoea

PDC Biotech, a privately held Austrian biopharmaceutical development company, is about to start a Phase I trial of PDC31 to treat otherwise healthy women with primary dysmenorrhoea, a disabling condition found in 10-15% of women of childbearing age which causes severe abdominal pain. The Phase I trial will be conducted at three clinical sites in Austria and in Germany and will evaluate the safety and pharmacokinetics of the compound as well as its effects on uterine contractility.

Gynecology & Urology Neurology

Recent Financings of Private Companies (12/2009)

Each month, Start-Up presents a comprehensive review of young, private life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals